Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Emeline Masson Frenet"'
Autor:
Hal E. Broxmeyer, Larry L Luchsinger, Rona S Weinberg, Alexandra Jimenez, Emeline Masson Frenet, Mark Kaplan, Scott Cooper, James Ropa
Publikováno v:
Blood. 140:10437-10438
Publikováno v:
Stem Cells Translational Medicine. 11:S35-S36
Introduction The National Cord Blood Program has a large inventory of clinical cord blood units (CBUs) available for transplant (more than 60,000). As a small proportion is distributed each year, new collections should theoretically replenish the inv
Autor:
Maude Dumont-Lagacé, Albert Feghaly, Marie-Christine Meunier, Marcie Finney, Wouter Van't Hof, Emeline Masson Frenet, Guy Sauvageau, Sandra Cohen
Publikováno v:
Transplantation and cellular therapy. 28(7)
Cord blood (CB) stem cell transplantation offers a greater tolerance to HLA mismatches compared to adult-derived stem cell transplants (i.e., bone marrow or peripheral blood stem cells). Indeed, 4/6 or 5/8 HLA-matched CB transplantations are regularl
Autor:
Emeline Masson Frenet, Chiseko Watanabe, Helen Bentsen, Bryana Chowtee, WenJun Liu, Cynthia Romeo, Dorothy Sung, Alexandra Jimenez
Publikováno v:
Stem Cells Translational Medicine. 11:S37-S37
Introduction Cord blood units (CBU) are tested at banking for markers relevant to donor safety (infectious disease markers) and hematopoietic stem cell transplantation (cellularity and HLA typing). As CBUs are being increasingly used for new, non-tra
Autor:
Anthony Blanco, Pinkal Desai, Sangmin Lee, Maria S. Albano, Michael Samuel, Ellen K. Ritchie, Joseph M. Scandura, Jeffrey Ball, Jingmei Hsu, Ludy Dobrila, Gail J. Roboz, Andromachi Scaradavou, Sebastian Mayer, Cynthia Romeo, Tsiporah B. Shore, Usama Gergis, Adrienne A. Phillips, Emeline Masson Frenet, Koen van Besien
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:466-473
Adoptive immunotherapy has shown efficacy in patients with relapsed/refractory acute myelogenous leukemia (AML). We conducted a prospective evaluation of cord blood (CB)-based adoptive cell therapy following salvage chemotherapy in patients with AML
Autor:
Andromachi Scaradavou, Sebastian Mayer, Adrienne A. Phillips, Cynthia Romeo, Tsiporah B. Shore, Usama Gergis, Ok-Kyong Chaekal, Melissa M. Cushing, Sangmin Lee, Ludy Dobrila, Ellen K. Ritchie, Maria S. Albano, Gail J. Roboz, Jingmei Hsu, Danielle Guarneri, Emeline Masson Frenet, Koen van Besien, Michael Samuel, Pinkal Desai, Nina Orfali
Publikováno v:
Blood Adv
We conducted a prospective evaluation of cord blood (CB)–derived adoptive cell therapy, after salvage chemotherapy, for patients with advanced myeloid malignancies and poor prognosis. Previously, we reported safety, feasibility, and preliminary eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f22349807b895dab6215556e7eb52017
https://europepmc.org/articles/PMC7594383/
https://europepmc.org/articles/PMC7594383/
Autor:
Suchitra S. Acharya, Judith Aeschlimann, Ahmad Al-Huniti, Ana G. Antun, Suzanne A. Arinsburg, Scott T. Avecilla, Burak Bahar, Debra Jo Bailey, Glaivy Batsuli, Henny H. Billett, Evan M. Bloch, Michael A. Briones, James B. Bussel, Marcus A. Carden, Wayne L. Chandler, Dong Chen, Marie Csete, Adam Cuker, Melissa M. Cushing, Jennifer Davila, Robert A. DeSimone, Roger Y. Dodd, Nancy M. Dunbar, Amy L. Dunn, Patrick A. Erdman, Ivo M.B. Francischetti, Richard O. Francis, Yelena Z. Ginzburg, Elizabeth A. Godbey, Ruchika Goel, Amit Gokhale, Yitz Goldstein, Jed B. Gorlin, Cheryl A. Goss, Janis R. Hamilton, Jeanne E. Hendrickson, Rong He, Christopher D. Hillyer, Eldad A. Hod, Yen-Michael S. Hsu, Heather A. Hume, Jack Jacob, Shilpa Jain, Florencia G. Jalikis, Alexandra Jimenez, Shawn M. Jobe, Cassandra D. Josephson, Matthew S. Karafin, Louis M. Katz, Christine L. Kempton, Debra A. Kessler, Margarita Kushnir, Michele P. Lambert, Marissa Li, Deepa Manwani, Irina Maramica, Susanne Marschner, Emeline Masson Frenet, Catherine E. McGuinn, Shannon L. Meeks, Connie H. Miller, Caterina P. Minniti, William B. Mitchell, Grace F. Monis, Theresa Nester, Philip Norris, Angela Novotny, Monika Paroder-Belenitsky, Shibani Pati, Kim Peck, Huy P. Pham, Allyson Pishko, Eva D. Quinley, Sabrina Racine-Brzostek, Lynsi Rahorst, Hanna Rennert, Joseph S.A. Restivo, Morayma Reyes Gil, Liz Rosenbaum-Marinaro, Mikhail Roshal, Sara Rutter, Bruce S. Sachais, Surbhi Saini, Susmita N. Sarangi, William J. Savage, Andromachi Scaradavou, Joseph Schwartz, Jansen N. Seheult, Eric Senaldi, Salima Shaikh, Anjali Sharathkumar, Beth H. Shaz, Patricia A. Shi, Sierra C. Simmons, Elizabeth M. Staley, Emily K. Storch, Donna Strauss, Yvette C. Tanhehco, Aaron A.R. Tobian, Christopher A. Tormey, Mary Townsend, Duc Q. Tran, Nancy L. Van Buren, Sunitha Vege, Randall Velliquette, Francesca Vinchi, Rona S. Weinberg, Stuart P. Weisberg, Connie M. Westhoff, Michael White, Anne M. Winkler, Lucia R. Wolgast, Kalinda Woods, Lina Y. Dimberg, Mark H. Yazer, Carolyn T. Young, Patricia E. Zerra, Karen L. Zimowski
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d072d8239a33073b8804f97eeef2514
https://doi.org/10.1016/b978-0-12-813726-0.01002-3
https://doi.org/10.1016/b978-0-12-813726-0.01002-3
The genes coding for the human leukocyte antigen (HLA) are located in the most polymorphic region of the human genome. HLA plays a central role in the immune response, making its exploration a key step in transfusion and transplantation. Testing for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fa031a4dee5bfd0991c9cd0ef3c406a
https://doi.org/10.1016/b978-0-12-813726-0.00032-5
https://doi.org/10.1016/b978-0-12-813726-0.00032-5
Autor:
Cynthia Romeo, Ludy Dobrila, Andromachi Scaradavou, Dorothy Sung, Tracy Zhu, Dan Zamfir, Michal Tarnawski, Chiseko Watanabe, Pablo Rubinstein, Maria S. Albano, Emeline Masson Frenet, Siddarth Krishnan
Publikováno v:
Blood. 132:2062-2062
Background: CBU selection for transplant is based on HLA match and potency/quality determinations associated with the speed of hematopoietic engraftment. Total Nucleated Cell (TNC) count, viable (v) CD45+ and CD34+ cells and Colony Forming Units (CFU
Autor:
Dorothy Sung, Pablo Rubinstein, Andromachi Scaradavou, Susana Albano, Rodica Ciubotariu, Cynthia Romeo, Ludy Dobrila, Emeline Masson Frenet, Michal Tarnawski
Publikováno v:
Human Immunology. 78:135
Aim Use of match probabilities is of great interest to reduce costs and delays in the search for a hematopoietic stem cell donor. Our aim was to estimate the accuracy and relevance of allele match probabilities provided by BMDW for patients (pts) wit